Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Kay

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|March 29, 1980
Zoster immune globulin for immunosuppressed childrenR S Lane, A Rankin, H E Kay
British Medical Journal|July 20, 1974
Fever in the neutropenic patientK Atkinson, H E Kay, T J McElwain
European Journal of Cancer|June 1, 1970
Further cytogenetical investigations in polycythaemia veraS D Lawler, R E Millard, H E Kay
Lancet (London, England)|May 22, 1971
Five-year analysis of protective isolationJ Lynch, B Jameson, D R Gamble, et al.
British Journal of Haematology|June 1, 1976
Analysis of treatment in childhood leukaemia. II. Timing and the toxicity of combined 6-mercaptopurine and methotrexate maintenance therapyI C MacLennan, H E Kay, M Festenstein, et al.
European Journal of Cancer|May 1, 1978
Surface characteristics of lymphoma cells in relation to treatment, response and survivalG Stathopoulos, H E Kay, I M Hamlin, et al.
Lancet (London, England)|November 6, 1982
Bone-marrow transplantation for acute leukaemia in first remissionR P Gale, H E Kay, A A Rimm, et al.
Lancet (London, England)|May 17, 1980
Cost of bone-marrow transplants in acute myeloid leukaemiaH E Kay, R L Powles, S D Lawler, et al.
JAMA|March 4, 1983
Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortalityM M Bortin, R P Gale, H E Kay, et al.
British Medical Journal|November 6, 1971
Lymphocyte transformation in patients with acute lymphoblastic leukaemiaL H Jones, R M Hardisty, D G Wells, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|March 29, 1980
Zoster immune globulin for immunosuppressed childrenR S Lane, A Rankin, H E Kay
British Medical Journal|July 20, 1974
Fever in the neutropenic patientK Atkinson, H E Kay, T J McElwain
European Journal of Cancer|June 1, 1970
Further cytogenetical investigations in polycythaemia veraS D Lawler, R E Millard, H E Kay
Lancet (London, England)|May 22, 1971
Five-year analysis of protective isolationJ Lynch, B Jameson, D R Gamble, et al.
British Journal of Haematology|June 1, 1976
Analysis of treatment in childhood leukaemia. II. Timing and the toxicity of combined 6-mercaptopurine and methotrexate maintenance therapyI C MacLennan, H E Kay, M Festenstein, et al.
European Journal of Cancer|May 1, 1978
Surface characteristics of lymphoma cells in relation to treatment, response and survivalG Stathopoulos, H E Kay, I M Hamlin, et al.
Lancet (London, England)|November 6, 1982
Bone-marrow transplantation for acute leukaemia in first remissionR P Gale, H E Kay, A A Rimm, et al.
Lancet (London, England)|May 17, 1980
Cost of bone-marrow transplants in acute myeloid leukaemiaH E Kay, R L Powles, S D Lawler, et al.
JAMA|March 4, 1983
Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortalityM M Bortin, R P Gale, H E Kay, et al.
British Medical Journal|November 6, 1971
Lymphocyte transformation in patients with acute lymphoblastic leukaemiaL H Jones, R M Hardisty, D G Wells, et al.
Pageof 8